<DOC>
	<DOCNO>NCT02458417</DOCNO>
	<brief_summary>The purpose study assess efficacy safety ReCell graft CO2 laser abrasion superficial full surface ablation , fractional laser treatment conventional ( deep ) full surface CO2 laser ablation , assess practical aspect patient report outcome ass cellular composition graft .</brief_summary>
	<brief_title>Autologous Cell Suspension Grafting Using ReCell Vitiligo Piebaldism Patients</brief_title>
	<detailed_description>Autologous epidermal cell suspension graft effective method surgical treatment vitiligo , suitable treat large area good cosmetic result . The ReCell Autologous Cell Harvesting Device ( Avita Medical Europe Limited , Cambridge , UK ) device , compare form autologous epidermal cell suspension grafting , easy use show similar result . With device epidermal cell suspension create split skin graft , usually take hip region . Currently , conventional ablative ( full surface de-epidermisation ) laser treatment different laser setting use pre-treatment prepare acceptor site transplantation . There evidence laser setting use study available use fractional laser pre-treatment autologous cell suspension graft use ReCell ( ReCell graft ) . The investigator hypothesize superficial conventional ablative laser treatment fractional ablative laser treatment effective current pre-treatment , whereas treatment less invasive , provide fast heal prevent side effect like persist erythema scar . Furthermore , infiltration anaesthesia necessary less invasive treatment .</detailed_description>
	<mesh_term>Vitiligo</mesh_term>
	<mesh_term>Piebaldism</mesh_term>
	<criteria>Patients , segmental vitiligo piebaldism medical treatment Netherlands Institute Pigment Disorders Age â‰¥18 Patient willing able give write informed consent Segmental vitiligo stable since 12 month without systemic therapy 12 month without topical therapy define absence new lesion and/or enlargement exist lesion . At least four depigmented lesion proximal extremity trunk large 3x3 cm one depigmented lesion proximal extremity trunk least 12x3 cm . UV therapy systemic immunosuppressive treatment last 12 month Local treatment vitiligo last 12 month Vitiligo lesion follicular nonfollicular repigmentations Skin type I Recurrent HSV skin infection Hypertrophic scar Keloid Cardiac insufficiency Patients history hypersensitivity ( UVB UVA ) light and/or allergy local anaesthesia . Patients pregnant breastfeed Patients competent understand procedure involve Patients personal history melanoma nonmelanoma skin cancer Patients atypical nevus . Known allergy clarithromycin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Ablative laser</keyword>
	<keyword>Fractional laser</keyword>
	<keyword>Vitiligo</keyword>
	<keyword>Piebaldism</keyword>
	<keyword>Cell suspension graft</keyword>
</DOC>